CME eps in a glimpse
Growth Next 5yrs
5.24%
Last Quarter
$2.68
Past Year
$9.67
Growth Past 5yrs
10.36%
Next Quarter
$2.60
Estimate Next Year
$1.98
Analyst Rating Consensus
Loading...
CME Price Target
Highest Price Target
$269.00
(
5.89% Upside
)Mean Price Target
$254.08
(
0.02% Upside
)Lowest Price Target
$212.00
(
-16.55% Downside
)CME Recent Analyst Ratings
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
CME Earnings History
After EPS - Where did the stock go?
Frequently Asked Questions
Is CME stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given CME stock an average recommendation of
Hold. 12 analysts have given their ratings
to CME out of which
2 analysts have given strong buy call,
0 analysts have given buy call,
9 analysts rate it hold,
1 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$254.08 gives the stock implied upside
of roughly 0.02% over the next year or so.
What have analysts suggested for CME highest price target?
Analysts suggest CME's stock price would rise to a high of $269.00.
What is the lowest price target analysts expect for CME over the next year?
Within the next 12 months, analysts predict the CME stock price could move to $212.00.
What is the average target price for CME?
CME stock has an average analyst estimate of $254.08.
At its current price, how far is CME from its average target price?
CME shares are currently trading 0.02% above this price target.
What were CME’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $2.68 versus consensus estimates of $2.65, and above the comparable year-ago quarter’s EPS of $2.26.
What are the current estimates for quarterly and annual earnings per share?
CME's forecasts by analysts estimating quarterly EPS at $2.60 and $1.98 for the whole year.
What has CME's growth been in the past five years and what is expected in the next five years?
The analysts have projected 5.24% EPS growth for CME in the next five years, compared to growth rates of 10.36% in the past five years.